BIOMAT Database Logo BIOMAT Database Logo

[Long-term treatment of acromegaly with bromocriptine (Parlodel R)]. 1977

R Dolecek, and M Závada

UI MeSH Term Description Entries
D008134 Long-Term Care Care over an extended period, usually for a chronic condition or disability, requiring periodic, intermittent, or continuous care. Care, Long-Term,Long Term Care
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001971 Bromocriptine A semisynthetic ergotamine alkaloid that is a dopamine D2 agonist. It suppresses prolactin secretion. 2-Bromoergocryptine,Bromocryptin,2-Bromo-alpha-ergocryptine,2-Bromo-alpha-ergokryptine,2-Bromoergocryptine Mesylate,2-Bromoergocryptine Methanesulfonate,2-Bromoergokryptine,Bromocriptin,Bromocriptine Mesylate,CB-154,Parlodel,2 Bromo alpha ergocryptine,2 Bromo alpha ergokryptine,2 Bromoergocryptine,2 Bromoergocryptine Mesylate,2 Bromoergocryptine Methanesulfonate,2 Bromoergokryptine,CB 154,CB154,Mesylate, 2-Bromoergocryptine,Mesylate, Bromocriptine,Methanesulfonate, 2-Bromoergocryptine
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000172 Acromegaly A condition caused by prolonged exposure to excessive HUMAN GROWTH HORMONE in adults. It is characterized by bony enlargement of the FACE; lower jaw (PROGNATHISM); hands; FEET; HEAD; and THORAX. The most common etiology is a GROWTH HORMONE-SECRETING PITUITARY ADENOMA. (From Joynt, Clinical Neurology, 1992, Ch36, pp79-80) Inappropriate Growth Hormone Secretion Syndrome (Acromegaly),Somatotropin Hypersecretion Syndrome (Acromegaly),Inappropriate GH Secretion Syndrome (Acromegaly),Hypersecretion Syndrome, Somatotropin (Acromegaly),Hypersecretion Syndromes, Somatotropin (Acromegaly),Somatotropin Hypersecretion Syndromes (Acromegaly),Syndrome, Somatotropin Hypersecretion (Acromegaly),Syndromes, Somatotropin Hypersecretion (Acromegaly)
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

R Dolecek, and M Závada
[Treatment of acromegaly with bromocriptine (Parlodel)].
May 1978, Ugeskrift for laeger,
R Dolecek, and M Závada
[Results of treatment for acromegaly with long-acting bromocriptine (Parlodel LAR)].
January 1993, Endokrynologia Polska,
R Dolecek, and M Závada
Long-term treatment of acromegaly with bromocriptine.
April 1977, British medical journal,
R Dolecek, and M Závada
Long-term treatment of acromegaly with bromocriptine.
April 1978, Acta endocrinologica,
R Dolecek, and M Závada
Acromegaly--results of long term treatment with bromocriptine.
January 1978, Acta endocrinologica. Supplementum,
R Dolecek, and M Závada
[Long-term use of parlodel in acromegaly].
January 1984, Terapevticheskii arkhiv,
R Dolecek, and M Závada
Long-term bromocriptine treatment and somatostatin in acromegaly.
October 1980, Endokrinologie,
R Dolecek, and M Závada
Treatment with long acting repeatable bromocriptine (Parlodel-LAR*) in patients with macroprolactinomas: long-term study in 29 patients.
January 1996, Journal of endocrinological investigation,
R Dolecek, and M Závada
Evaluation of a repeatable depot-bromocriptine preparation(Parlodel LAR) for the treatment of acromegaly.
December 1991, Journal of endocrinological investigation,
R Dolecek, and M Závada
New long-acting bromocriptine (Parlodel MR and Parlodel LAR) in the treatment of pituitary tumours with hyperprolactinemia.
January 1992, Endokrynologia Polska,
Copied contents to your clipboard!